No one left behind: generational transfer of knowledge as essential for universal quality treatment
Interview Medicine Equality Now!In Kazakhstan, many people living with HIV waited for years to access treatment with old generation antiretrovirals (ARVs). These medicines...
-
Access to optimal treatment for HIV in Kazakhstan: as prices go down, so does stigma
Interview Medicine Equality Now! NewsMMA’s campaign partner in Kazakhstan, Answer, focuses on reducing prices, and improving access to optimal treatment for HCV, viral hepatitis...
Read more about Access to optimal treatment for HIV in Kazakhstan: as prices go down, so does stigma
-
Leaders of the 21 nations of APEC have pledged urgent action to tackle the pandemic
InterviewThe 21 leaders of the Asia-Pacific Economic Cooperation met last Friday, 16th of July, (albeit virtually) to pledge urgent action...
Read more about Leaders of the 21 nations of APEC have pledged urgent action to tackle the pandemic
-
COVID-19 Community Resource: resource for access to COVID-19 medical technology
ResearchCOVID-19 has revealed – and drastically worsened – economic and social inequality on a global scale. Governmental decisions to prioritize...
Read more about COVID-19 Community Resource: resource for access to COVID-19 medical technology
-
Brazilian House of Representatives approves bill to suspend patents: finally lives before profits?
Medicine Equality Now! NewsTwo months ago, the Brazilian Senate approved a law project bill (Law Project 12/21) that allows the country to expand...
-
Samarn: Activists fought for my right to survive – and won
Interview Medicine Equality Now! News“Back in 1994, when I was in my early 20s, I fell ill while doing construction work in Bangkok. That’s...
Read more about Samarn: Activists fought for my right to survive – and won
-
Thailand’s opposition against Gilead’s patent application: overcharging what?
Medicine Equality Now! NewsEarlier this month, Thai civil society opposed Gilead’s Sciences’ patent application on remdesivir, which has been trialled in the treatment...
Read more about Thailand’s opposition against Gilead’s patent application: overcharging what?
